1. Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
   Laura M. Urbanski et al, 2018, WIREs RNA CrossRef
2. Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells
   Renan B. Ferreira et al, 2017, Oncotarget CrossRef